Literature DB >> 10980736

Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR).

A Coeytaux1, P Jallon, B Galobardes, A Morabia.   

Abstract

BACKGROUND: To determine the incidence, risk factors, and case fatality rate of status epilepticus (SE) in the French-speaking part of Switzerland.
METHODS: Between October 1, 1997 and September 30, 1998 all cases of SE referred to all the hospitals in the six cantons of the French-speaking part of Switzerland were identified by physicians working in emergency rooms, intensive care units, and electroencephalography departments; neurologists; and pediatricians from all hospitals in the area. Each case was validated and classified according to seizure type and etiology.
RESULTS: Over 1 year, 172 cases were identified, of whom 74 had a history of epilepsy (42.4%). The crude and standardized annual incidence rate were 9.9/100,000 (95% CI, 8.4 to 11.4) and 10.3/100,000 (95% CI, 8.7 to 11.9). The incidence rate was higher among children < 1 year of age and adults > 65 years, and among men than women. There were 108 cases of acute symptomatic SE (incidence: 6.2 per 1000), 49 cases of remote symptomatic SE, and 15 cases of unknown etiology. Case fatality rate was 7.6%.
CONCLUSIONS: The standardized incidence rate of SE in the French-speaking part of Switzerland was lower than that reported in Rochester, MN (18.3/100,000) and in the white population of Richmond, VA (20/100,000). The discrepancy may stem from the lack of a homogeneous, rigorous, and pragmatic definition of SE and the efficient management of acute repetitive seizures in this area.

Entities:  

Mesh:

Year:  2000        PMID: 10980736     DOI: 10.1212/wnl.55.5.693

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  63 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists.

Authors:  M Holtkamp; F Masuhr; L Harms; K M Einhäupl; H Meierkord; K Buchheim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

Review 3.  Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus.

Authors:  Karthik Rajasekaran; Santina A Zanelli; Howard P Goodkin
Journal:  Semin Pediatr Neurol       Date:  2010-09       Impact factor: 1.636

4.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

Review 5.  Status epilepticus: an evidence based guide.

Authors:  Matthew Walker
Journal:  BMJ       Date:  2005-09-24

Review 6.  Outcome of convulsive status epilepticus: a review.

Authors:  Claire L Novorol; Richard F M Chin; Rod C Scott
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

7.  Predictors of outcome in acute encephalitis.

Authors:  Kiran T Thakur; Melissa Motta; Anthony O Asemota; Hannah L Kirsch; David R Benavides; Eric B Schneider; Justin C McArthur; Romergryko G Geocadin; Arun Venkatesan
Journal:  Neurology       Date:  2013-07-26       Impact factor: 9.910

8.  Inappropriate emergency management of status epilepticus in children contributes to need for intensive care.

Authors:  R F M Chin; L Verhulst; B G R Neville; M J Peters; R C Scott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

9.  Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts.

Authors:  Luca Vignatelli; Rita Rinaldi; Elisa Baldin; Paolo Tinuper; Roberto Michelucci; Massimo Galeotti; Piero de Carolis; Roberto D'Alessandro
Journal:  J Neurol       Date:  2008-01-23       Impact factor: 4.849

10.  Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes.

Authors:  Utku Uysal; Mark Quigg; Brennen Bittel; Nancy Hammond; Theresa I Shireman
Journal:  Epilepsy Res       Date:  2015-07-26       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.